作者: D. Sanyal , S. Chatterjee
DOI: 10.1111/AND.12480
关键词:
摘要: This retrospective study assessed treatment preferences and outcome with testosterone or HCG / HCG-FSH combination in Indian male idiopathic hypogonadotropic hypogonadism (IHH) subjects (n = 31) above 18 years of age. 38.7% IHH had no fertility plans chose 3 monthly intramuscular undecanoate. 73.7% human chorionic gonadotropin (HCG) alone due to cost considerations. Spermatogenesis occurred 21.4% on 60% follicle-stimulating hormone (FSH) combination. Treatment failure is higher than published Western rates. FSH regimen costly but superior alone. However, still persists, suggesting unknown testicular defect IHH.